F-star

F-star Biotechnology Ltd.
Industry Pharmaceutical
Headquarters Cambridge, UK
Website www.f-star.com

F-star Biotechnology Ltd. is a biotechnology company originally founded in Vienna, with a current main research site in Cambridge, UK. The company is focused in developing bispecific monoclonal antibodies using a modular combinatorial approach that engineers the Fc constant region of an immunoglobulin into a novel antigen-binding site.[1][2]

See also

  1. ↑ http://www.f-star.com
  2. ↑ Wozniak-Knopp G, Bartl S, Bauer A, Mostageer M, Woisetschläger M, Antes B, Ettl K, Kainer M, Weberhofer G, Wiederkum S, Himmler G, Mudde GC, Rüker F (2010). "Introducing antigen-binding sites in structural loops of immunoglobulin constant domains: Fc fragments with engineered HER2/neu-binding sites and antibody properties.". Protein Eng Des. 23 (4): 289–297. doi:10.1093/protein/gzq005. PMID 20150180.
This article is issued from Wikipedia - version of the 5/30/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.